Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;32(1):59-65.
doi: 10.4103/0974-8520.85729.

Clinical Efficacy of Coleus Forskohlii (Willd.) Briq. (Makandi) in Hypertension of Geriatric Population

Affiliations
Free PMC article

Clinical Efficacy of Coleus Forskohlii (Willd.) Briq. (Makandi) in Hypertension of Geriatric Population

Madhavi Jagtap et al. Ayu. .
Free PMC article

Abstract

Hypertension is the most common psychosomatic disorder affecting 972 million people worldwide. The present clinical study deals with the effect of Makandi (Coleus forskohlii (Willd.) Briq.) Ghana vati and tablets of its powder in hypertension found in the geriatric age group (50-80 years). A total of 49 hypertensive patients fulfilling the diagnostic criteria were registered in two groups-Group I (Ghana vati) and Group II (Churna tablet). Out of 27 enrolled patients of group I, 21 patients completed the treatment. In Group II, out of 22 registered patients, a total of 20 patients completed the treatment. The effect of the therapy was assessed on the basis of changes in the systolic and diastolic blood pressures, in both sitting and supine positions; with Manasa Bhava Pariksha, Manasa Vibhrama Pariksha, symptomatology, geriatric signs and symptoms, and a brief psychiatric rating scale. Analysis of the results showed that the treatment in both the groups had been found to be good. It can be stated that Makandi, either in Ghana vati form or in churna tablet form, is an effective remedy for the treatment of hypertension. On analyzing the overall effect, 76.19% patients in Group I and 75.00% patients in Group II were mildly improved. Comparatively the overall treatment with group I was found to be better.

Keywords: Coleus forskohlii; Ghana vati; Makandi; forskolin; geriatric hypertension.

Figures

Figure 1
Figure 1
Overall effect of therapy

Similar articles

See all similar articles

Cited by 1 article

References

    1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: Analysis of worldwide data. [Last assessed on 2010 Apr 23];Lancet. 2005 365:21723. Available from: http://www.sld.cu/galerias/pdf/servicios/hta/global_burden_of_hypertension.pdf . - PubMed
    1. Gupta R, Al-Odat NA, Gupta VP. Hypertension epidemiology in India: Meta-analysis of 50 year prevalence rates and blood pressure trends. J Hum Hypertens. 1996;10:465–72. - PubMed
    1. Gupta R. Major coronary risk factors and coronary heart disease epidemic in India. South Asian J Prev Cardiol. 2003;7:11–40. quoted in article-‘Increased variance in blood pressure distribution and changing hypertension prevalence in an urban Indian population’ downloaded from http://www.nature.com/jhh/journal/v17/n8/pdf/1001588a.pdf. on 23/4/2010.
    1. Indias older population quadruple by 2050. [Last accessed on 2010 Mar 20]. p. 1. Available from: http://www.indianexpress.com .
    1. Khemaraj Shrikrushnadasa prakashana. Mumbai: 1993. Shaligram Nighantu- Bhushnam, Lala-Shaligramji- vaishya virachita, sanskaran. Parishishta Bhaga; p. 931.
Feedback